Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GRDX
Entero Therapeutics
$3.81
-1.3%		$3.35
$1.87
▼
$6.93
$27.74M1.87101,527 shs99,781 shs
Infobird Co., Ltd. stock logo
IFBD
Infobird
$1.13
+14.7%		$1.01
$0.66
▼
$2.18
$5.18M1.453,115 shs9.14 million shs
MIND C.T.I. Ltd. stock logo
MNDO
MIND C.T.I.
$1.02
$1.02
$0.85
▼
$1.29
$19.78M0.3944,043 shs12,285 shs
TGHL
GrowHub
$0.83
+0.5%		$0.84
$0.27
▼
$2.48
$21MN/A118,775 shs42,981 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GRDX
Entero Therapeutics
-0.77%+31.29%+5.75%-10.85%+385,999,900.00%
Infobird Co., Ltd. stock logo
IFBD
Infobird
+7.35%+5.06%+1.08%+2.66%-26.73%
MIND C.T.I. Ltd. stock logo
MNDO
MIND C.T.I.
+4.07%-2.86%+0.99%+0.99%-14.26%
TGHL
GrowHub
-0.54%+0.54%+5.78%+81.51%-51.99%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GRDX
Entero Therapeutics
$3.81
-1.3%		$3.35
$1.87
▼
$6.93
$27.74M1.87101,527 shs99,781 shs
Infobird Co., Ltd. stock logo
IFBD
Infobird
$1.13
+14.7%		$1.01
$0.66
▼
$2.18
$5.18M1.453,115 shs9.14 million shs
MIND C.T.I. Ltd. stock logo
MNDO
MIND C.T.I.
$1.02
$1.02
$0.85
▼
$1.29
$19.78M0.3944,043 shs12,285 shs
TGHL
GrowHub
$0.83
+0.5%		$0.84
$0.27
▼
$2.48
$21MN/A118,775 shs42,981 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GRDX
Entero Therapeutics
-0.77%+31.29%+5.75%-10.85%+385,999,900.00%
Infobird Co., Ltd. stock logo
IFBD
Infobird
+7.35%+5.06%+1.08%+2.66%-26.73%
MIND C.T.I. Ltd. stock logo
MNDO
MIND C.T.I.
+4.07%-2.86%+0.99%+0.99%-14.26%
TGHL
GrowHub
-0.54%+0.54%+5.78%+81.51%-51.99%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GRDX
Entero Therapeutics
0.00
N/AN/AN/A
Infobird Co., Ltd. stock logo
IFBD
Infobird
1.00
SellN/AN/A
MIND C.T.I. Ltd. stock logo
MNDO
MIND C.T.I.
1.00
SellN/AN/A
TGHL
GrowHub
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest IFBD, MNDO, GRDX, and TGHL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/28/2026
Infobird Co., Ltd. stock logo
IFBD
Infobird
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/21/2026
TGHL
GrowHub
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
8/13/2026
Infobird Co., Ltd. stock logo
IFBD
Infobird
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/11/2026
MIND C.T.I. Ltd. stock logo
MNDO
MIND C.T.I.
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C-) ➝ Sell (D)
7/17/2026
Infobird Co., Ltd. stock logo
IFBD
Infobird
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
6/30/2026
Infobird Co., Ltd. stock logo
IFBD
Infobird
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
(Data available from 9/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GRDX
Entero Therapeutics
$40K679.13N/AN/A$7.42 per share0.51
Infobird Co., Ltd. stock logo
IFBD
Infobird
$8.71M0.71N/AN/A$3.34 per share0.34
MIND C.T.I. Ltd. stock logo
MNDO
MIND C.T.I.
$19.46M1.06$0.15 per share6.95$1.13 per share0.90
TGHL
GrowHub
$60K349.98N/AN/A($0.09) per share-9.22
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GRDX
Entero Therapeutics
-$6.39M-$1.90N/AN/AN/AN/A-47.34%-16.07%N/A
Infobird Co., Ltd. stock logo
IFBD
Infobird
-$57.19MN/AN/AN/AN/AN/AN/AN/AN/A
MIND C.T.I. Ltd. stock logo
MNDO
MIND C.T.I.
$2.60M$0.166.38N/AN/A16.87%14.09%10.90%11/11/2026 (Estimated)
TGHL
GrowHub
-$13.38MN/AN/AN/AN/AN/AN/AN/AN/A

Latest IFBD, MNDO, GRDX, and TGHL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/24/2026Q2 2026
Infobird Co., Ltd. stock logo
IFBD
Infobird
N/A-$0.94N/A-$0.94N/A$0.93 million
8/6/2026Q2 2026
MIND C.T.I. Ltd. stock logo
MNDO
MIND C.T.I.
N/A$0.04N/A$0.04N/A$4.61 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
GRDX
Entero Therapeutics
N/AN/AN/AN/AN/A
Infobird Co., Ltd. stock logo
IFBD
Infobird
N/AN/AN/AN/AN/A
MIND C.T.I. Ltd. stock logo
MNDO
MIND C.T.I.
N/AN/A-1.72%N/AN/A
TGHL
GrowHub
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GRDX
Entero Therapeutics
N/A
0.16
0.16
Infobird Co., Ltd. stock logo
IFBD
Infobird
0.01
1.98
1.98
MIND C.T.I. Ltd. stock logo
MNDO
MIND C.T.I.
N/A
4.66
4.66
TGHL
GrowHub
N/A
0.29
0.29

Institutional Ownership

CompanyInstitutional Ownership
GRDX
Entero Therapeutics
12.30%
Infobird Co., Ltd. stock logo
IFBD
Infobird
2.93%
MIND C.T.I. Ltd. stock logo
MNDO
MIND C.T.I.
24.32%
TGHL
GrowHub
N/A

Insider Ownership

CompanyInsider Ownership
GRDX
Entero Therapeutics
0.75%
Infobird Co., Ltd. stock logo
IFBD
Infobird
35.48%
MIND C.T.I. Ltd. stock logo
MNDO
MIND C.T.I.
N/A
TGHL
GrowHub
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
GRDX
Entero Therapeutics
27.13 million7.08 millionN/A
Infobird Co., Ltd. stock logo
IFBD
Infobird
485.46 million3.52 millionNot Optionable
MIND C.T.I. Ltd. stock logo
MNDO
MIND C.T.I.
13920.18 millionN/AOptionable
TGHL
GrowHub
725.30 millionN/AN/A

Recent News About These Companies

GrowHub Shareholders Approve Major Capital Increase and Reverse Split Structure
August 6, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/growhub-shareholders-approve-major-capital-increase-and-reverse-split-structure?utm_source=marketbeat.com&utm_medium=referral
GrowHub Limited Calls August 5 EGM to Approve Major Capital Increase and Reverse Share Split
July 17, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/growhub-limited-calls-august-5-egm-to-approve-major-capital-increase-and-reverse-share-split?utm_source=marketbeat.com&utm_medium=referral
Growhub (TGHL) stock is trending overnight—here's why it jumped 73% after hours
July 17, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/growhub-tghl-stock-is-trending-overnight-here-s-why-it-jumped-73-after-hours/ar-AA280nYs
The GrowHub Limited (TGHL) Stock Soars on a Merger Update
July 16, 2026  |  tipranks.comhttps://www.tipranks.com/news/the-growhub-limited-tghl-stock-soars-on-a-merger-update?utm_source=marketbeat.com&utm_medium=referral
GrowHub shares fell following Nasdaq staff's delisting determination; company plans to appeal
June 10, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4602139-the-growhub-to-request-hearing-following-nasdaq-delisting-determination
THE GROWHUB LIMITED Announces Receipt of Nasdaq Staff Determination Letter and Intention to Request Hearing
June 10, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/the-growhub-limited-announces-receipt-of-nasdaq-staff-determination-letter-and-intention-to-request-hearing-302795131.html
GrowHub Faces Nasdaq Delisting After Compliance Lapse, Plans Appeal
June 9, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/growhub-faces-nasdaq-delisting-after-compliance-lapse-plans-appeal?utm_source=marketbeat.com&utm_medium=referral
The Growhub Limited (TGHL)
June 1, 2026  |  sg.finance.yahoo.comhttps://sg.finance.yahoo.com/quote/TGHL/press-releases/
GrowHub shares surge as company outlines reverse-merger plan with EnChem America
June 1, 2026  |  quiverquant.comQ
GrowHub Signs Binding Reverse Merger Deal With EnChem America
June 1, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/growhub-signs-binding-reverse-merger-deal-with-enchem-america?utm_source=marketbeat.com&utm_medium=referral
THE GROWHUB LIMITED Announces Receipt of Nasdaq Notification Letter Regarding Stockholders' Equity Deficiency
May 29, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/the-growhub-limited-announces-receipt-of-nasdaq-notification-letter-regarding-stockholders-equity-deficiency-302785439.html
The GrowHub Limited Receives Nasdaq Notice Over Stockholders’ Equity Shortfall
May 28, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/the-growhub-limited-receives-nasdaq-notice-over-stockholders-equity-shortfall?utm_source=marketbeat.com&utm_medium=referral
GrowHub Limited Class A
April 16, 2026  |  edition.cnn.comhttps://edition.cnn.com/markets/stocks/TGHL
Nature's Capital: Why Asia's Governments Are Turning to Nature-Based Solutions
March 16, 2026  |  taiwannews.com.twT
GrowHub Limited Names Assentsure PAC as New Independent Auditor
March 6, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/growhub-limited-names-assentsure-pac-as-new-independent-auditor?utm_source=marketbeat.com&utm_medium=referral
Asia's Carbon Moment: From Agreement to Action
March 6, 2026  |  manilatimes.netM
TGHL The Growhub Limited
February 22, 2026  |  seekingalpha.comhttps://seekingalpha.com/symbol/TGHL
The GrowHub Limited Overhauls Board and Committees With New Director Appointments
February 17, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/the-growhub-limited-overhauls-board-and-committees-with-new-director-appointments?utm_source=marketbeat.com&utm_medium=referral
GrowHub announces board resignations and new CFO appointment
December 31, 2025  |  msn.comhttps://www.msn.com/en-us/money/other/growhub-announces-board-resignations-and-new-cfo-appointment/ar-AA1TjyNb
The GrowHub Limited files unaudited interim financials showing ongoing shareholders’ deficit
December 23, 2025  |  msn.comhttps://www.msn.com/en-us/money/markets/the-growhub-limited-files-unaudited-interim-financials-showing-ongoing-shareholders-deficit/ar-AA1SVC6I

New MarketBeat Followers Over Time

Media Sentiment Over Time

Entero Therapeutics NASDAQ:GRDX

$3.81 -0.05 (-1.30%)
Closing price 04:00 PM Eastern
Extended Trading
$3.92 +0.12 (+3.02%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of targeted and orally delivered therapies for the treatment of patients with gastrointestinal diseases. The company's pipeline candidates include latiglutenase, a targeted oral biotherapeutic for celiac disease designed to breakdown gluten into non-immunogenic peptides, currently under Phase 2 studies; and capeserod, a selective 5-HT4 receptor partial agonist under Phase 1 studies for the treatment of gastroparesis. It is also involved in the development of adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients, currently under Phase 2 studies for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis and chronic pancreatitis; and niclosamide, an oral small molecule with anti-inflammatory inhibitor therapy, currently under Phase 2 studies for the treatment of ulcerative proctitis and ulcerative proctosigmoiditis, as well as immune checkpoint inhibitor-associated colitis and diarrhea in metastatic cancer patients. The company was formerly known as First Wave BioPharma, Inc. and changed its name to Entero Therapeutics, Inc. in May 2024. Entero Therapeutics, Inc. was incorporated in 2014 and is based in Boca Raton, Florida.

Infobird stock logo

Infobird NASDAQ:IFBD

$1.13 +0.14 (+14.66%)
Closing price 04:00 PM Eastern
Extended Trading
$1.62 +0.49 (+43.10%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Infobird Co., Ltd, through its subsidiaries, operates as a software-as-a-service (SaaS) provider of artificial intelligence (AI) enabled customer engagement solutions in the People's Republic of China. The company offers customer relationship management cloud-based services, such as SaaS and business process outsourcing services to its clients. It also provides AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to enable its clients to monitor, benchmark, and enhance the performances of agents; consumer product and retail store digitalization solutions; and other services, including software license selling, data analysis, and other professional services. The company serves corporate clients in the finance, education, public services, healthcare, and consumer products industries. Infobird Co., Ltd was founded in 2001 and is based in Beijing, the People's Republic of China.

MIND C.T.I. stock logo

MIND C.T.I. NASDAQ:MNDO

$1.02 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.01 -0.01 (-1.18%)
As of 04:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MIND C.T.I. Ltd., together with its subsidiaries, develops, markets, sells, and implements billing and customer care software solutions for communication service providers in the Americas, Europe, Israel, the Asia Pacific, and Africa. It operates in two segments, Billing and Related Services, and Messaging. The company offers billing and customer care solutions that support various services, such as voice, data, and content services, as well as prepaid, postpaid, and pay-in-advance payment models in a single platform. Its solutions also include a workflow engine to support the implementation of business processes, including subscriber registration, order management, trouble ticket, and debt collection; and a point of sale solution that covers dealer, store and cashier management, and sales cycle related activities. In addition, the company offers professional services comprising turnkey project delivery, customer support and maintenance, integration, customizations, and project management; and managed services, including day to day billing operational tasks. Further, it provides PhonEX ONE, a call management system that collects, records, and stores call information, which is used by organizations for telecom expense management, call accounting, traffic analysis, and fraud detection; and a mobile messaging platform. The company offers its products directly, as well as through distributors and resellers primarily to communication service providers, such as traditional wireline and wireless, voice over IP, broadband IP network operators, wireless internet service providers, LTE operators, cable operators, and mobile virtual network operators. MIND C.T.I. Ltd. was incorporated in 1995 and is headquartered in Yokneam Illit, Israel.

GrowHub NASDAQ:TGHL

$0.83 +0.00 (+0.52%)
Closing price 03:56 PM Eastern
Extended Trading
$0.83 0.00 (-0.12%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Our Company operates at the intersection of technology and supply chain management, focusing on enhancing product traceability and authenticity. With a commitment to innovation and sustainability, we have developed a multi-faceted approach to address industry challenges. Our business currently comprises two main divisions, which are the GrowHub Platform and our product trading facilitation offering, and we currently preparing for the launch of our third main business division, namely, the GrowHub Innovation Centre, which is expected to start generating material revenue by the end of the second quarter of 2025. Each division will play a vital role in our mission to improve transparency and efficiency in businesses. Central to the Company’s operations is the proprietary GrowHub Platform, a revolutionary traceability blockchain technology solution. We believe that as of the date of this prospectus, we are among the few entities in Asia Pacific that operates a public blockchain system whereby all data can be transmitted directly to the cloud and shown on public blockchain records, and not subject to possible tampering and alteration of data. The GrowHub Platform stands as the cornerstone of our Company’s operations, serving as our main business and flagship offering. --- Hosted on the robust Polygon network (i.e. a third-party blockchain platform which aims to create a multi-chain blockchain system compatible with Ethereum, a decentralized blockchain with smart contract functionality), the GrowHub Platform represents a paradigm shift in the way food products are traced from origin to consumer. Unlike traditional systems, the GrowHub Platform harnesses the power of public blockchain technology with an aim to ensure data immutability and transparency. Every aspect of the supply chain is meticulously recorded as an immutable checkpoint, each capturing critical information such as ingredient sourcing, manufacturing processes, and distribution channels. Through a seamless web application and QR code integration, consumers gain access to comprehensive product provenance, empowering them to make informed purchasing decisions with confidence. The GrowHub Platform offers three key solutions: the traceability solution that provides comprehensive tracking of products throughout the supply chain; the anti-counterfeit solution that equips organizations with tools to combat counterfeiting; and the carbon management solution that empowers companies to track and manage carbon emissions, contributing to environmental sustainability. Our vision is to empower the world to consume with confidence. Our mission is to enhance transparency throughout the supply chain by harnessing advancing technology, fostering trust, and amplifying stakeholder voices. By doing so, we aim to instill confidence in consumers, enhance operational efficiency for businesses, and drive data-driven decision-making within the industry. Our principal place of business is in Singapore.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas